RTI Surgical (RTIX) vs. Coloplast (CLPBY) Critical Review

RTI Surgical (NASDAQ: RTIX) and Coloplast (OTCMKTS:CLPBY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability and dividends.

Risk & Volatility

RTI Surgical has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Coloplast has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500.

Profitability

This table compares RTI Surgical and Coloplast’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
RTI Surgical 2.57% 2.49% 1.24%
Coloplast 24.10% 74.60% 31.46%

Valuation & Earnings

This table compares RTI Surgical and Coloplast’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
RTI Surgical $279.56 million 1.01 $6.27 million $0.05 89.00
Coloplast $2.31 billion 8.09 $564.23 million N/A N/A

Coloplast has higher revenue and earnings than RTI Surgical.

Analyst Ratings

This is a breakdown of recent ratings and target prices for RTI Surgical and Coloplast, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RTI Surgical 0 0 1 0 3.00
Coloplast 0 0 0 0 N/A

Insider & Institutional Ownership

68.0% of RTI Surgical shares are held by institutional investors. Comparatively, 0.1% of Coloplast shares are held by institutional investors. 4.4% of RTI Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dividends

Coloplast pays an annual dividend of $0.10 per share and has a dividend yield of 1.1%. RTI Surgical does not pay a dividend.

Summary

Coloplast beats RTI Surgical on 7 of the 11 factors compared between the two stocks.

RTI Surgical Company Profile

RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.

Coloplast Company Profile

Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Urology Care, and Wound & Skin Care. It provides ostomy care products for intestinal dysfunction resulting from disease, accident, and congenital disorder. The company's ostomy care products include colostomy, ileostomy, and urostomy bags under the SenSura brand; and SenSura Mio, a colostomy product with elastic adhesive that fits individual body shapes, as well as ostomy accessories under the Brava brand. It also offers urology care products for people suffering from diseases and symptoms of the urinary system, pelvic floor prolapse, and the male reproductive system, such as urinary incontinence, kidney stones, enlarged prostate, and impotence. The company's disposable surgical devices include prostate catheters and stents used for urological and gynecological applications before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. In addition, it provides continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. Further, the company offers wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as disinfectant liquids or creams used to protect and treat the skin and to clean wounds. Additionally, it offers Interdry, a textile placed in a skin fold to absorb moisture for treatment and prevention of skin fold problems, such as fungal infections, damaged skin, or odour nuisance. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply